These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Efficacy and Safety of Clopidogrel, Prasugrel and Ticagrelor in ACS Patients Treated with PCI: A Propensity Score Analysis of the RENAMI and BleeMACS Registries. Peyracchia M; Saglietto A; Biolè C; Raposeiras-Roubin S; Abu-Assi E; Kinnaird T; Ariza-Solé A; Liebetrau C; Manzano-Fernández S; Boccuzzi G; Henriques JPS; Wilton SB; Velicki L; Xanthopoulou I; Correia L; Rognoni A; Fabrizio U; Nuñez-Gil I; Montabone A; Taha S; Fujii T; Durante A; Gili S; Magnani G; Autelli M; Grosso A; Kawaji T; Blanco PF; Garay A; Quadri G; Queija BC; Huczek Z; Paz RC; González-Juanatey JR; Fernández MC; Nie SP; D'Amico M; Pousa IM; Kawashiri MA; Gallo D; Morbiducci U; Dominguez-Rodriguez A; Lopez-Cuenca A; Cequier A; Alexopoulos D; Iñiguez-Romo A; Grossomarra W; Usmiani T; Rinaldi M; D'Ascenzo F Am J Cardiovasc Drugs; 2020 Jun; 20(3):259-269. PubMed ID: 31586336 [TBL] [Abstract][Full Text] [Related]
4. High bleeding risk patients with acute coronary syndromes treated with contemporary drug-eluting stents and Clopidogrel or Ticagrelor: Insights from CHANGE DAPT. Zocca P; Kok MM; van der Heijden LC; van Houwelingen KG; Hartmann M; de Man FHAF; Stoel MG; Louwerenburg JHW; Knottnerus IL; Linssen GCM; Doggen CJM; von Birgelen C Int J Cardiol; 2018 Oct; 268():11-17. PubMed ID: 29801763 [TBL] [Abstract][Full Text] [Related]
5. Safety of Clopidogrel vs. Ticagrelor in Dual Antiplatelet Therapy Regimens for High-Bleeding Risk Acute Coronary Syndrome Patients: A Comprehensive Meta-analysis of Adverse Outcomes. Khalid AR; Ahmad F; Naeem MAB; Ahmed S; Umar M; Mehmood H; Kashif M; Ali S High Blood Press Cardiovasc Prev; 2024 Mar; 31(2):141-155. PubMed ID: 38557855 [TBL] [Abstract][Full Text] [Related]
6. Bleeding risk and P2Y12 inhibitors in all-comer patients with ST-segment elevation myocardial infarction treated with percutaneous coronary intervention: a single-centre cohort study. Jacobsen MR; Jabbari R; Engstrøm T; Grove EL; Glinge C; Pedersen F; Holmvang L; Køber L; Torp-Pedersen C; Maeng M; Veien K; Freeman P; Charlot MG; Kelbæk H; Sørensen R Eur Heart J Cardiovasc Pharmacother; 2023 Nov; 9(7):617-626. PubMed ID: 37403404 [TBL] [Abstract][Full Text] [Related]
7. Ticagrelor versus clopidogrel in acute myocardial infarction patients with multivessel disease; From Korea Acute Myocardial Infarction Registry-National Institute of Health. Ahn JH; Ahn Y; Jeong MH; Kim JH; Hong YJ; Sim DS; Kim MC; Hwang JY; Yoon JH; Seong IW; Hur SH; Oh SK; J Cardiol; 2020 May; 75(5):478-484. PubMed ID: 31859138 [TBL] [Abstract][Full Text] [Related]
8. Features of antiplatelet therapy with P2Y12 receptor inhibitors in patients with myocardial infarction according to the Russian Register of Acute Myocardial Infarction REGION-MI. Boytsov SA; Shakhnovich RM; Tereschenko SN; Erlikh AD; Kukava NG; Pevsner DV; Rytova YK Kardiologiia; 2022 Sep; 62(9):44-53. PubMed ID: 36206137 [TBL] [Abstract][Full Text] [Related]
9. Net clinical benefit of different strategies of dual antiplatelet therapy in elderly patients: Data from the praise registry. D'Ascenzo F; Elia E; de Filippo O; Manai R; Breviario S; Bruno F; Iannaccone M; Wańha W; Bianco M; Patti G; Raposeiras-Roubin S; Abu-Assi E; Bo M; De Ferrari GM; Conrotto F; Int J Cardiol; 2022 Apr; 353():9-14. PubMed ID: 35090983 [TBL] [Abstract][Full Text] [Related]
10. Clinical Outcomes of Ticagrelor in Korean Patients with Acute Myocardial Infarction without High Bleeding Risk. Park KH; Jeong MH; Kim HK; Ki YJ; Kim SS; Choi DH; Koh YY; Ahn Y; Kim HS; Gwon HC; Rha SW; Hwang JY; J Korean Med Sci; 2021 Nov; 36(42):e268. PubMed ID: 34725976 [TBL] [Abstract][Full Text] [Related]
11. Long versus short dual antiplatelet therapy in acute coronary syndrome patients treated with prasugrel or ticagrelor and coronary revascularization: Insights from the RENAMI registry. D'Ascenzo F; Bertaina M; Fioravanti F; Bongiovanni F; Raposeiras-Roubin S; Abu-Assi E; Kinnaird T; Ariza-Solé A; Manzano-Fernández S; Templin C; Velicki L; Xanthopoulou I; Cerrato E; Rognoni A; Boccuzzi G; Omedè P; Montabone A; Taha S; Durante A; Gili S; Magnani G; Autelli M; Grosso A; Blanco PF; Garay A; Quadri G; Varbella F; Queija BC; Paz RC; Fernández MC; Pousa IM; Gallo D; Morbiducci U; Dominguez-Rodriguez A; Valdés M; Cequier A; Alexopoulos D; Iñiguez-Romo A; Gaita F; Rinaldi M; Lüscher TF Eur J Prev Cardiol; 2020 May; 27(7):696-705. PubMed ID: 30862233 [TBL] [Abstract][Full Text] [Related]
12. Outcomes in patients treated with ticagrelor versus clopidogrel after acute myocardial infarction stratified by renal function. Edfors R; Sahlén A; Szummer K; Renlund H; Evans M; Carrero JJ; Spaak J; James SK; Lagerqvist B; Varenhorst C; Jernberg T Heart; 2018 Oct; 104(19):1575-1582. PubMed ID: 29574413 [TBL] [Abstract][Full Text] [Related]
13. Comparison of Clinical Outcomes Between Ticagrelor and Clopidogrel in East-Asian Patients with Acute Coronary Syndrome: Large Cohort Study. Lee WC; Fang CY; Tsai YH; Hsieh YY; Chen TY; Fang YN; Chen HC; Wu PJ; Fang HY Am J Cardiovasc Drugs; 2023 Sep; 23(5):573-581. PubMed ID: 37610643 [TBL] [Abstract][Full Text] [Related]
14. Utility of GRACE and ACUITY-HORIZONS risk scores to guide dual antiplatelet therapy in Korean patients with acute myocardial infarction undergoing drug-eluting stenting. Sim DS; Jeong MH; Kim HS; Gwon HC; Seung KB; Rha SW; Chae SC; Kim CJ; Cha KS; Park JS; Yoon JH; Chae JK; Joo SJ; Choi DJ; Hur SH; Seong IW; Cho MC; Kim DI; Oh SK; Ahn TH; Hwang JY; J Cardiol; 2018 Nov; 72(5):411-419. PubMed ID: 29764713 [TBL] [Abstract][Full Text] [Related]
15. Prognosis and the Effect of De-Escalation of Antiplatelet Therapy After Nuisance Bleeding in Patients With Myocardial Infarction. Choo EH; Choi IJ; Lim S; Moon D; Kim CJ; Park MW; Kim MC; Hwang BH; Lee KY; Seok Choi Y; Kim HY; Yoo KD; Jeon DS; Ahn Y; Chang K; Circ Cardiovasc Interv; 2022 Dec; 15(12):e012157. PubMed ID: 36382599 [TBL] [Abstract][Full Text] [Related]
16. Efficacy and Safety of Ticagrelor vs. Clopidogrel in East Asian Patients with Acute Myocardial Infarction: A Nationwide Cohort Study. Chang CJ; Tung YC; Liu JR; Chang SH; Kuo CT; See LC Clin Pharmacol Ther; 2021 Feb; 109(2):443-451. PubMed ID: 32767756 [TBL] [Abstract][Full Text] [Related]
17. Association of Ticagrelor vs Clopidogrel With Net Adverse Clinical Events in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention. You SC; Rho Y; Bikdeli B; Kim J; Siapos A; Weaver J; Londhe A; Cho J; Park J; Schuemie M; Suchard MA; Madigan D; Hripcsak G; Gupta A; Reich CG; Ryan PB; Park RW; Krumholz HM JAMA; 2020 Oct; 324(16):1640-1650. PubMed ID: 33107944 [TBL] [Abstract][Full Text] [Related]
18. Clopidogrel versus ticagrelor for antiplatelet therapy in transcarotid artery revascularization in the Society for Vascular Surgery Vascular Quality Initiative. Ghamraoui AK; Chang H; Maldonado TS; Ricotta JJ J Vasc Surg; 2022 May; 75(5):1652-1660. PubMed ID: 34920001 [TBL] [Abstract][Full Text] [Related]
19. Risk of Major Bleeding With Potent Antiplatelet Agents After an Acute Coronary Event: A Comparison of Ticagrelor and Clopidogrel in 5116 Consecutive Patients in Clinical Practice. Mullen L; Meah MN; Elamin A; Aggarwal S; Shahzad A; Shaw M; Hasara J; Rashid M; Fisher M; Ali T; Patel B; Ding WY; Grainger R; Heseltine T; Kirmani BH; Obeidat M; Kasolo Y; Thatchil J; Khand A J Am Heart Assoc; 2021 Apr; 10(8):e019467. PubMed ID: 33834845 [TBL] [Abstract][Full Text] [Related]
20. Ticagrelor in Triple Antithrombotic Therapy: Predictors of Ischemic and Bleeding Complications. Fu A; Singh K; Abunassar J; Malhotra N; Le May M; Labinaz M; Glover C; Marquis JF; Froeschl M; Dick A; Hibbert B; Chong AY; So DY; Clin Cardiol; 2016 Jan; 39(1):19-23. PubMed ID: 26748815 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]